Effect of process variables on particle size and viability of Bifidobacterium lactis Bb-12 in genipin-gelatin microspheres

Journal of Microencapsulation

Volumn 24, Issue 2, 2007, Pages 152-162

  Annan, N T ^a   Borza, A ^a   Moreau, D L ^b   Allan Wojtas, P M ^b   Hansen, L Truelstrup ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

^b AGRICULTURE AND AGRI FOOD CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG CARRIER; GELATIN; GENIPIN; PROBIOTIC AGENT; SURFACTANT; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL CELL; BIFIDOBACTERIUM ANIMALIS; BIODEGRADABILITY; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; CROSS LINKING; DRUG DELIVERY SYSTEM; DRUG STABILITY; EMULSION; MICROENCAPSULATION; NONHUMAN; PARTICLE SIZE; PRINCIPAL COMPONENT ANALYSIS; SCANNING ELECTRON MICROSCOPY; SIMULATION; STOMACH JUICE;

BIFIDOBACTERIUM; CELL SURVIVAL; GELATIN; IRIDOIDS; MICROSCOPY, ELECTRON, SCANNING; MICROSPHERES; PARTICLE SIZE; SURFACE-ACTIVE AGENTS;

EID: 33947632952     PISSN: 02652048     EISSN: 14645246     Source Type: Journal    
DOI: 10.1080/02652040601162475     Document Type: Article

References (26)

1. Akao, T., Kobashi, K. and Aburada, M. (1994) Enzymatic studies on the animal and intestinal bacterial metabolism of geniposide. Biological and Pharmaceutical Bulletin, 17, pp. 1573-1576.
2. Anonymous (1992) Yoghurt and probiotics. Choice, 32, pp. 32-35.
3. Arshady, R. (1990) Albumin microspheres and microcapsules: Methodology of manufacturing techniques. Journal of Controlled Release, 14, pp. 111-131.
4. Chang, TM and Prakash, S. (1997) Artificial cells for bioencapsulation of cells and genetically engineered E. coli for cell therapy, gene therapy, and removal of urea and ammonia. Methods in Molecular Biology, 63, pp. 343-358.
5. 1 from microspheres embedded within biodegradable hydrogels. Biomaterials, 27, pp. 1579-1585.
6. Digenis, GA, Gold, TB and Shah, VP (1994) Cross-linking of gelatin capsules and its relevance to their in vitro-in vivo performance. Journal of Pharmaceutical sciences, 83, pp. 915-921.
7. Dinarvand, R., Mahmoodi, S. and Farboud, E. (2004) Effect of process variables on particle size of gelatin microspheres containing lactic acid. Pharmaceutical Development and technology, 9, pp. 291-299.
8. Esposito, E., Cortesi, R. and Nastruzzi, C. (1996) Gelatin microspheres: Influence of preparation parameters and thermal treatment on chemico-physical and biopharmaceutical properties. Biomaterials, 17, pp. 2009-2020.
9. Fuller, R. (1989) Probiotics in man and animals: A review. Journal of Applied Bacteriology, 66, pp. 365-378.
10. Jin, J., Song, M. and Hourston, DJ (2004) Novel chitosan-based films cross-linked by genipin with improved physical properties. Biomacromolecules, 5, pp. 162-168.
11. Kong, HJ, Smith, MK and Mooney, DJ (2003) Designing alginate hydrogels to maintain viability of immobilized cells. Biomaterials, 24, pp. 4023-4029.
12. Krasaekoopt, W., Bhandari, B. and Deeth, H. (2003) Evaluation of encapsulation techniques of probiotics for yoghurt. International Dairy Journal, 13, pp. 3-13.
13. Lee, YK and Salminen, S. (1995) The coming to age of probiotics. Trends in Food Science and Technology, 6, pp. 241-245.
14. Liang, HC, Chang, WH, Lin, KJ and Sung, HW (2002) Genipin-cross-linked gelatin microspheres as a drug carrier for intramuscular administration: In vitro and in vivo studies. Journal of Biomedical Materials Research Part A, 65, pp. 271-282.
15. Narayani, R. and Rao, PK (1995) pH-Responsive gelatin microspheres for oral delivery of anticancer drug methotrexate. Journal of Applied Polymer Science, 58, pp. 1761-1769.
16. Prakash, S. and Jones, ML (2005) Artificial cell therapy: New strategies for the therapeutic delivery of live bacteria. Journal of Biomedicine and Biotechnology, 1, pp. 44-56.
17. Robinson, RK (1987) Survival of L. acidophilus in fermented products. Suid Afikanese Tydskrif Vir Suiwelkunde, 19, pp. 25-27.
18. Scardi, V. (1987) Immobilization of enzymes and microbial cells in gelatin. Methods in Enzymology, 135, pp. 293-299.
19. Simulated Gastric Fluid (2000) The National Formulary 18 Board of Trustees, United States Pharmacopeial Convention, Rockville, MD
20. Sung, HW, Huang, DM, Chang, WH, Huang, RN and Hsu, JC (1999) Evaluation of gelatin hydrogel cross-linked with various cross-linking agents as bioadhesives: In vitro study. Journal of Biomedical Materials Research, 46, pp. 520-530.
21. Touyama, R., Takeda, Y., Inoue, K., Kawamura, I., Yatsuzuka, M., Ikumoto, T., Shingu, T., Yokoi, T. and Inouye, H. (1994) Studies on the blue pigments produced from genipin and methylamine I Structures of the brownish-red pigments, intermediates leading to the blue pigments. Chemical and Pharmaceutical Bulletin, 42, pp. 668-673.
22. Hansen, L Truelstrup, Allan-Wojtas, PM, Jin, Y-L and Paulson, AT (2002) Survival of Ca-alginate microencapsulated Bifidobacterium spp in milk and simulated gastrointestinal conditions. Food Microbiology, 19, pp. 35-45.
23. Tsai, CC, Huang, RN, Sung, HC and Liang, HC (2000) In vitro evaluation of the genotoxicity of a naturally occurring cross-linking reagent for biological tissue fixation. Journal of Biomedical Materials Research, 52, pp. 58-65.
24. Ugwoke, MI and Kinget, R. (1998) Influence of processing variables on the properties of gelatin microspheres prepared by the emulsification solvent extraction technique. Journal of Microencapsulation, 15, pp. 273-281.
25. Vandelli, MA, Rivasi, F., Guerra, P., Forni, F. and Arletti, R. (2001) Gelatin microspheres cross-linked with D,L-glyceraldehyde as a potential drug delivery system: Preparation, characterization, in vitro and in vivo studies. International Journal of Pharmaceutics, 215, pp. 175-184.
26. Zhang, CY, Parton, LE, Ye, CP, Krauss, S., Shen, R., Lin, CT, Porco, JA and Lowell, BB (2006) Genipin inhibits UCP2-mediated proton leak and acutely reverses obesity- and high glucose-induced β-cell dysfunction in isolated pancreatic islets. Cell Metabolism, 3, pp. 417-427.